These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 27888437

  • 21. Smoking Cessation Pharmacotherapy Utilization and Costs to a Medicaid Managed Care Plan.
    Corelli RL, Tu TG, Lee KJ, Dinh D, Gericke KR, Hudmon KS.
    Pharmacoecon Open; 2021 Dec; 5(4):649-653. PubMed ID: 34109569
    [Abstract] [Full Text] [Related]

  • 22. Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States.
    Borer JS, Kansal AR, Dorman ED, Krotneva S, Zheng Y, Patel HK, Tavazzi L, Komajda M, Ford I, Böhm M, Kielhorn A.
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1064-71. PubMed ID: 27579829
    [Abstract] [Full Text] [Related]

  • 23. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
    Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.
    Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
    [Abstract] [Full Text] [Related]

  • 24. Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans.
    Li Y, Heer AK, Sloane HS, Edelstein DL, Tie J, Gibbs P, Barzi A.
    JAMA Health Forum; 2024 May 03; 5(5):e241270. PubMed ID: 38819797
    [Abstract] [Full Text] [Related]

  • 25. Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis.
    Sung HY, Penko J, Cummins SE, Max W, Zhu SH, Bibbins-Domingo K, Kohatsu ND.
    Am J Prev Med; 2018 Dec 03; 55(6 Suppl 2):S148-S158. PubMed ID: 30454669
    [Abstract] [Full Text] [Related]

  • 26. Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives.
    Yang J, Liu R, Ektare V, Stephens J, Shelbaya A.
    Appl Health Econ Health Policy; 2021 Jul 03; 19(4):605-618. PubMed ID: 33506318
    [Abstract] [Full Text] [Related]

  • 27. The Growing Proportion of Smokers in Medicaid and Implications for Public Policy.
    Zhu SH, Anderson CM, Wong S, Kohatsu ND.
    Am J Prev Med; 2018 Dec 03; 55(6 Suppl 2):S130-S137. PubMed ID: 30454667
    [Abstract] [Full Text] [Related]

  • 28. Integrated budget impact model to estimate the impact of introducing selpercatinib as a tumor-agnostic treatment option for patients with RET-altered solid tumors in the US.
    Bhandari NR, Gilligan AM, Myers J, Ale-Ali A, Smolen L.
    J Med Econ; 2024 Dec 03; 27(1):348-358. PubMed ID: 38334069
    [Abstract] [Full Text] [Related]

  • 29. Medicaid Tobacco Cessation: Big Gaps Remain In Efforts To Get Smokers To Quit.
    Ku L, Bruen BK, Steinmetz E, Bysshe T.
    Health Aff (Millwood); 2016 Jan 03; 35(1):62-70. PubMed ID: 26733702
    [Abstract] [Full Text] [Related]

  • 30. Effect of Gaining Insurance Coverage on Smoking Cessation in Community Health Centers: A Cohort Study.
    Bailey SR, Hoopes MJ, Marino M, Heintzman J, O'Malley JP, Hatch B, Angier H, Fortmann SP, DeVoe JE.
    J Gen Intern Med; 2016 Oct 03; 31(10):1198-205. PubMed ID: 27329121
    [Abstract] [Full Text] [Related]

  • 31. Healthcare Costs of Smokers Using Varenicline Versus Nicotine-Replacement Therapy Patch in the United States: Evidence from Real-World Practice.
    Lee LJ, Li Q, Bruno M, Emir B, Murphy B, Shah S, Reynolds M, Marchant N, Park PW.
    Adv Ther; 2019 Feb 03; 36(2):365-380. PubMed ID: 30569324
    [Abstract] [Full Text] [Related]

  • 32. State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Coverage - United States, 2014-2015.
    Singleterry J, Jump Z, DiGiulio A, Babb S, Sneegas K, MacNeil A, Zhang L, Williams KA.
    MMWR Morb Mortal Wkly Rep; 2015 Oct 30; 64(42):1194-9. PubMed ID: 26513425
    [Abstract] [Full Text] [Related]

  • 33. Smoking cessation in a blue-collar population: results from an evidence-based pilot program.
    Ringen K, Anderson N, McAfee T, Zbikowski SM, Fales D.
    Am J Ind Med; 2002 Nov 30; 42(5):367-77. PubMed ID: 12382249
    [Abstract] [Full Text] [Related]

  • 34. A ready-to-use liquid glucagon for treatment of severe hypoglycemia demonstrates reduced healthcare payer costs in a budget impact model.
    Leinwand B, Johnsrud M, Nguyen A, Meyer J, Johnson K.
    J Med Econ; 2020 Jul 30; 23(7):744-750. PubMed ID: 32162983
    [Abstract] [Full Text] [Related]

  • 35. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
    Linden K, Jormanainen V, Linna M, Sintonen H, Wilson K, Kotomäki T.
    Curr Med Res Opin; 2010 Mar 30; 26(3):549-60. PubMed ID: 20050814
    [Abstract] [Full Text] [Related]

  • 36. Helping smokers quit--opportunities created by the Affordable Care Act.
    McAfee T, Babb S, McNabb S, Fiore MC.
    N Engl J Med; 2015 Jan 01; 372(1):5-7. PubMed ID: 25409263
    [No Abstract] [Full Text] [Related]

  • 37. Cost impact of different treatment regimens of brolucizumab in neovascular age-related macular degeneration: A budget impact analysis.
    Siddiqui ZA, Dhumal T, Patel J, LeMasters T, Almony A, Kamal KM.
    J Manag Care Spec Pharm; 2022 Dec 01; 28(12):1350-1364. PubMed ID: 36427338
    [Abstract] [Full Text] [Related]

  • 38. Affordable Care Act Medicaid expansion and access to primary-care based smoking cessation assistance among cancer survivors: an observational cohort study.
    Bailey SR, Voss R, Angier H, Huguet N, Marino M, Valenzuela SH, Chung-Bridges K, DeVoe JE.
    BMC Health Serv Res; 2022 Apr 12; 22(1):488. PubMed ID: 35414079
    [Abstract] [Full Text] [Related]

  • 39. Analysis of Actual Versus Projected Medical Claims Under the First Year of ACA-Mandated Coverage.
    McCue MJ, Palazzolo JR.
    Inquiry; 2016 Apr 12; 53():. PubMed ID: 27856783
    [Abstract] [Full Text] [Related]

  • 40. The financial implications of coverage of smoking cessation treatment by managed care organizations.
    Warner KE, Mendez D, Smith DG.
    Inquiry; 2004 Apr 12; 41(1):57-69. PubMed ID: 15224960
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.